Shin Nippon Biomedical Laboratories Management
Management criteria checks 2/4
Shin Nippon Biomedical Laboratories' El consejero delegado es Ryoichi Nagata , nombrado en Jan 1991, tiene un mandato de 32.92 años. posee directamente 2.46% de las acciones de la empresa, con un valor de €10.60M . La antigüedad media del equipo directivo y del consejo de administración es de 1.7 años y 8.5 años, respectivamente.
Key information
Ryoichi Nagata
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 33.3yrs |
CEO ownership | 2.5% |
Management average tenure | 2yrs |
Board average tenure | 8.8yrs |
Recent management updates
Recent updates
CEO
Ryoichi Nagata (65 yo)
33.3yrs
Tenure
JP¥144,061,000
Compensation
Dr. Ryoichi Nagata, M.D., Ph D., F.F.P.M., serves as President & Director of Satsuma Pharmaceuticals, Inc. since June 8, 2023 Also serves as it's Chief Executive Officer. He has been the President of Shin...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 33.3yrs | JP¥144.06m | 2.46% ¥ 9.0m | |
Senior Executive Officer | 2.3yrs | no data | no data | |
Managing Executive Officer and GM of IR Public Relations Department & Sustainability | 1.3yrs | no data | no data | |
Senior MD of Corporate Development & Corporate Tax Administration and Director | 1.8yrs | no data | no data | |
Managing Executive Officer | no data | no data | no data | |
Executive VP of Group Corporate Management & Global Business & Director | 19.8yrs | no data | 0.088% ¥ 323.3k | |
Senior MD | 1.3yrs | no data | no data | |
Managing Executive Officer | no data | no data | no data | |
Senior MD & Director | no data | no data | 0.043% ¥ 159.5k | |
Executive VP | no data | no data | 37.87% ¥ 138.9m | |
Managing Executive Officer and GM of Corporate Strategy Headquarters & Corporate Planning Department | no data | no data | no data | |
GM of Business IT Promotion Department | no data | no data | no data |
2.0yrs
Average Tenure
56yo
Average Age
Equipo directivo experimentado: YB3El equipo directivo de la empresa se considera experimentado (2 años de antigüedad media).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 41yrs | JP¥144.06m | 2.46% ¥ 9.0m | |
Senior MD of Corporate Development & Corporate Tax Administration and Director | 13.8yrs | no data | no data | |
Managing Executive Officer | no data | no data | no data | |
Executive VP of Group Corporate Management & Global Business & Director | 21.3yrs | no data | 0.088% ¥ 323.3k | |
Senior MD | 9.8yrs | no data | no data | |
Senior MD & Director | 9.8yrs | no data | 0.043% ¥ 159.5k | |
Executive VP | 3.8yrs | no data | 37.87% ¥ 138.9m | |
Independent Outside Director | 8.8yrs | no data | no data | |
Independent Outside Director | 8.8yrs | no data | no data | |
Full-Time Auditor | 3.8yrs | no data | 0.015% ¥ 55.5k | |
Independent Outside Director | 3.8yrs | no data | 0.0079% ¥ 29.1k | |
Independent Outside Director | 2.8yrs | no data | no data |
8.8yrs
Average Tenure
59yo
Average Age
Junta con experiencia: La junta directiva de YB3 se considera experimentada (8.5 años de antigüedad promedio).